scholarly journals Novel insights into the BAP1-inactivated melanocytic tumor

2021 ◽  
Author(s):  
Michele Donati ◽  
Petr Martinek ◽  
Petr Steiner ◽  
Petr Grossmann ◽  
Tomas Vanecek ◽  
...  
Keyword(s):  
2005 ◽  
Vol 32 (2) ◽  
pp. 125-130 ◽  
Author(s):  
H. Wu ◽  
A. Barusevicius ◽  
J. Babb ◽  
A. Klein-Szanto ◽  
A. Godwin ◽  
...  

2014 ◽  
Vol 41 (6) ◽  
pp. 529-535 ◽  
Author(s):  
Maria M. De la Garza Bravo ◽  
Jonathan L. Curry ◽  
Carlos A. Torres-Cabala ◽  
Doina S. Ivan ◽  
Carol Drucker ◽  
...  

2020 ◽  
Author(s):  
K. G. P. Kerckhoffs ◽  
T. Aallali ◽  
C. A. Ambarus ◽  
V. Sigurdsson ◽  
A. M. L. Jansen ◽  
...  

Abstract The molecular background of a significant proportion of spitzoid neoplasms is still unknown. Recently, activating mutations in MAP2K1 have been described in a few spitzoid lesions, but not in benign Spitz nevi. We report four cases of melanocytic tumors with spitzoid features in which a MAP2K1 mutation was detected. The lesions did not show a single distinct phenotype and ranged from benign to malignant. Two cases resembled desmoplastic Spitz nevi. Based on the combination of morphological, immunohistochemical, and molecular findings, one case was classified as benign, one as probably benign, possibly intermediate low-grade (MELTUMP—melanocytic tumor of unknown malignant potential), one case was classified as intermediate (MELTUMP), and one case was considered a superficial spreading melanoma with spitzoid features. Based on this, we conclude that MAP2K1 mutations can indicate a spitzoid genetic signature and can be found in both benign and malignant spitzoid neoplasms.


2016 ◽  
Vol 32 (12) ◽  
pp. 636-637
Author(s):  
Lung-Che Chen ◽  
Yi-Zhi Lin ◽  
Te-Ming Tseng ◽  
Shih-Han Hung

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Nives Jonjić ◽  
Andrea Dekanić ◽  
Nedeljka Glavan ◽  
Larisa Prpić-Massari ◽  
Blaženka Grahovac

A case of a 41-year-old woman with a history of nodular melanoma (NM), associated with an indurated dome-shaped blue-black nodule with a diameter of 1.2 cm in the gluteal region, is presented. Clinical diagnosis of the lesion, present from birth, was blue nevus. Recently, the nodule has been showing a mild enlargement and thus complete resection was performed. Histological analysis revealed a pigmented lesion with an expansive pattern of extension into the dermis and the subcutaneous adipose tissue. The lesion displayed an alveolar pattern as well as a pigmented dendritic cell pattern. The histology was consistent with cellular blue nevus (CBN); however, the history of NM which was excised one year earlier, as well as the clinical information about the slow growing lesion, included a differential diagnosis of CBN, borderline melanocytic tumor, and malignant blue nevus. Additional immunohistochemical (HMB-45, p16, and Ki-67) and molecular (BRAF V600E mutation) analyses were performed on both lesions: the CBN-like and the previously excised NM. Along with lesion history and histological analyses, p16 staining and BRAF were useful diagnostic tools for confirming the benign nature of CBN in this case.


2011 ◽  
Vol 65 (2) ◽  
pp. e57-e58 ◽  
Author(s):  
Antonio D'Antonio ◽  
Roberto Cuomo ◽  
Basilio Angrisani ◽  
Domenico Memoli ◽  
Pasquale Angrisani
Keyword(s):  

Oncogene ◽  
1999 ◽  
Vol 18 (3) ◽  
pp. 837-842 ◽  
Author(s):  
Masashi Kato ◽  
Wei Liu ◽  
Anwarul A Akhand ◽  
Yan Dai ◽  
Masaharu Ohbayashi ◽  
...  

1999 ◽  
Vol 30 (5) ◽  
pp. 525-529 ◽  
Author(s):  
Stephen E Pool ◽  
Fariba Manieei ◽  
Wallace H Clark ◽  
Terence J Harrist
Keyword(s):  

2020 ◽  
Vol 47 (5) ◽  
pp. 459-461
Author(s):  
Lyn M. Duncan ◽  
Michael T. Tetzlaff
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document